phrykt

Apnimed, Inc. (APMD): who owns it and who trades it

As of Nov 16, 2026, APMD insiders reported 2 purchases worth $5.2M in the last 12 months. The largest buyer was Morningside Venture Investments Ltd (10% owner), with $5M. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Apnimed

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, APMD insiders reported $5.2M of open-market purchases and $0 of sales.

Purchases, 12 months
$5.2M
2 trades, 2 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Aug 3, 2026
Filed Aug 5, 2026

Purchases and sales by month

$5.2M$5.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 3, 2026Morningside Venture Investments Ltd10% ownerPurchase312,500$16.00$5MForm 4
Aug 3, 2026Paul J SekhriDirectorPurchase12,500$16.00$200KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Morningside Venture Investments Ltd10% owner$5M–Aug 3, 2026
Paul J SekhriDirector$200K–Aug 3, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

APMD short interest

Low short interest. 3.8% of APMD shares are sold short: about 1 share in 26. Over the last 6 reports the number of shares short went up 289%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.59M APMD shares were sold short, 3.8% of the shares outstanding, down 12.0% from the report before. At the average daily volume of 349,282 shares, buying them all back would take about 4.5 trading days (days to cover).

Shares short, % of all shares

3.81%Sep 15Oct 304.67%

Days to cover

4.5Aug 14Oct 305.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.59M3.81%-12%349,2824.5
Oct 15, 20261.80M4.33%+2%466,5053.9
Sep 30, 20261.76M4.24%+101%843,0782.1
Sep 15, 2026879,6842.11%+56%271,2983.2
Aug 31, 2026564,832–+39%374,0861.5
Aug 14, 2026407,565––411,4651.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Apnimed company events

Apnimed filed 2 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 8, 2026.

  1. Sep 8, 2026ResultsReleased financial results. Filing
  2. Aug 3, 2026RulesChanged its bylaws or articles. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Famous investors that hold APMD

1 of the 50 well-known investors we track reported holding APMD in their latest 13F filing. The largest position is Ken Griffin's, worth $11.3M.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026517,646$11.3M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named APMD in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Morningside Venture Investments Ltd13G17.4%
Nov 16, 2026Miller Lawrence G.13G6.2%
Nov 16, 2026Miller Lawrence G.13G6.2%
Nov 16, 2026Morningside Venture Investments Ltd13G17.4%
Nov 4, 2026SHIONOGI & CO LTD13G7.1%
Nov 4, 2026SHIONOGI & CO LTD13G7.1%

Questions about Apnimed, Inc. (APMD) stock

Are APMD insiders buying or selling?

In the last 12 months, APMD insiders reported 2 open-market purchases worth $5.2M and no sales. The latest trade was on Aug 3, 2026. See every trade.

What is the short interest in APMD?

As of Oct 30, 2026, 1.59M APMD shares were sold short, 3.8% of the shares outstanding, down 12.0% from the report before. At the average daily volume of 349,282 shares, buying them all back would take about 4.5 trading days (days to cover). See the history.

Which famous investors hold APMD?

1 of the 50 well-known investors we track reported APMD in their latest 13F filing, including Ken Griffin. The largest position is worth $11.3M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.